Evidence map›Paper›PMID 30479584›Full record

ArticleClinical proteomics2018

Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts.

Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Nandini A Sahasrabuddhe, Raghothama Chaerkady, Mi-Sik Kim, Mary Jo Fackler, Martha Stampfer, Edward Gabrielson, Saraswati Sukumar and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical proteomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Xinyan Wu *1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA.
Muhammad Saddiq Zahari *1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA.
Santosh Renuse *1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA.
Nandini A Sahasrabuddhe1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA.
Raghothama Chaerkady1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA.
Mi-Sik Kim1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA.
Mary Jo Fackler5Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Martha Stampfer7Division of Biological Systems and Engineering, Lawrence Berkeley National Laboratory, Berkeley, CA USA.
Edward Gabrielson5Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Saraswati Sukumar5Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Akhilesh Pandey1Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD USA.ORCID 0000-0001-9943-6127

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1186/s12014-018-9197-x.].

Identifiers

PMID30479584
PMCPMC6240261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.